Common Equity: The sum of all common equity items.
Korro Bio, Inc. (KRRO) had Common Equity of $51.44M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$6.39M |
|
$-117.26M |
|
-- |
|
$6.39M |
|
$128.25M |
|
$-121.86M |
|
$5.23M |
|
$-116.62M |
|
$-116.62M |
|
$-117.26M |
|
$-117.26M |
|
$-117.26M |
|
$-117.26M |
|
$-121.86M |
|
$-118.06M |
|
9.39M |
|
9.39M |
|
$-12.48 |
|
$-12.48 |
|
| Balance Sheet Financials | |
$82.37M |
|
$8.16M |
|
$31.13M |
|
$113.51M |
|
$11.94M |
|
-- |
|
$50.13M |
|
$62.07M |
|
|
Common Equity |
$51.44M |
$51.44M |
|
$51.44M |
|
9.42M |
|
| Cash Flow Statement Financials | |
$-78.56M |
|
$43.99M |
|
$0.69M |
|
$59.05M |
|
$25.23M |
|
$-33.82M |
|
$7.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1906.37% |
|
-1906.37% |
|
-1847.06% |
|
-1824.52% |
|
-1834.48% |
|
$-79.08M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
6.60 |
|
55.33 |
|
-227.96% |
|
-227.96% |
|
-103.31% |
|
-227.96% |
|
$5.46 |
|
$-8.42 |
|
$-8.36 |
|